The pharmaceutical stock is struggling, but its dividend can be highly valuable to income investors.
Latest News
BofA stays bullish on a cloud titan that is down 25%
Oracle faces a sharp divide between equity and credit investors. Discover why BofA reiterates a $240 price target despite massive AI capital expenditures.
Diamondback Energy: The Next Catalyst May Have Nothing To Do With Oil
Diamondback Energy is a Buy: strong Q2 free cash flow, buybacks/dividends, debt paydown, and Bryant Ranch gas upside. Click for more on FANG stock.
Top 3 Price Prediction: Bitcoin, Ethereum, Ripple – BTC consolidates near recent highs, ETH and XRP defend key bullish supports
Ethereum (ETH) and Ripple (XRP) maintain a constructive outlook on Monday after gaining more than 3.4%, 4% and 4.8%, respectively, last week. BTC holds
Three Cryptocurrency Stocks Poised for Growth This September: Coinbase (COIN), Circle, and Robinhood (HOOD)
Circle, and Robinhood (HOOD) stand out as key crypto stocks to monitor this September amid Bitcoin’s recovery rally.
Meet the AI Infrastructure Stock That Has Tripled in 2026 (Hint: It Can Still Double)
Seagate released its fiscal 2026 fourth-quarter results (for the quarter ended July 3) on July 29. The company’s annual revenue increased by 34% to
Upstox launches US stocks investing, offers access to 8,000 stocks, 2,000 ETFs
Upstox on Monday announced the launch of US stocks investing on its platform, allowing Indian investors to buy and sell more than 8,000 US-listed
US Adds 162,000 Jobs, Triple Expectations, Putting Bitcoin, ETH and XRP on Rate Hike Watch
Key Takeaways The US added 162,000 jobs in August, roughly triple expectations, while unemployment remained unchanged at 4.1%. The surprise pushed the estimated probability
Five Market Events to Watch This Week: U.S. Inflation, ECB Rates, Iran and Earnings
Chart with magnifying glass ©Adobe Stock Images U.S. inflation figures, the European Central Bank’s interest-rate decision and developments in the Iran conflict are among
Palantir, Pfizer and 5 options strategies – “No option premium will save you” from a bad stock
After more than 25 years of options trading and seeing thousands of trades, the creator says he has narrowed his approach to just five